Microsatellite instability-high colorectal cancer
Clinical trials for Microsatellite instability-high colorectal cancer explained in plain language.
Never miss a new study
Get alerted when new Microsatellite instability-high colorectal cancer trials appear
Sign up with your email to follow new studies for Microsatellite instability-high colorectal cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Watch and wait: could immunotherapy let some GI cancer patients avoid surgery?
Disease control Recruiting nowThis study looks at people with early-stage gastrointestinal cancers that have a mismatch repair deficiency, a feature that can make tumors respond well to immunotherapy. Part A is a registry that tracks all such patients, whether they have surgery or immunotherapy. Part B follow…
Matched conditions: MICROSATELLITE INSTABILITY-HIGH COLORECTAL CANCER
Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill takes on brain tumors and metastases in early trial
Disease control Recruiting nowThis study tests an oral drug called NEO212 in people with specific brain tumors (astrocytoma, glioblastoma) or cancers that have spread to the brain. The goal is to find the safest dose and see if it helps control tumor growth. About 134 adults will take NEO212 alone or with sta…
Matched conditions: MICROSATELLITE INSTABILITY-HIGH COLORECTAL CANCER
Phase 1/2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug FOG-001 takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial is testing a new drug, FOG-001, in about 595 people with advanced or metastatic solid tumors, including colorectal, prostate, and liver cancers. The drug is given alone or with other cancer treatments to see if it is safe and shrinks tumors. The study is cu…
Matched conditions: MICROSATELLITE INSTABILITY-HIGH COLORECTAL CANCER
Phase 1/2 • Sponsor: Parabilis Medicines, Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Why does immunotherapy fail in some bowel cancer patients? new study aims to find out
Knowledge-focused Recruiting nowThis study will follow 600 people with a specific type of advanced colorectal cancer (MSI-high) who are being treated with the immunotherapy drug pembrolizumab. The goal is to understand why about 20-30% of patients do not respond to this treatment. By analyzing tumor samples and…
Matched conditions: MICROSATELLITE INSTABILITY-HIGH COLORECTAL CANCER
Sponsor: Federation Francophone de Cancerologie Digestive • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC